Fortrea Clinical Research Unit - Dallas

Dallas, Texas 75247-4989

0 studies enrolling now · 12 studies all time

What they study most

Atopic Dermatitis, Healthy Participants, Healthy Volunteers, Obesity, Overweight, Overweight and Obesity, Pharmacokinetics

Studies at this site

• A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity — Completed
• Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose. — Running, not enrolling
• Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity — Running, not enrolling
• A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants — Completed
• Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose — Running, not enrolling
• Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations — Completed
• A Study to Evaluate the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of ZN-A-1041 in Healthy Participants — Completed
• Effect of Maridebart Cafraglutide on the Heart's Electrical Activity — Running, not enrolling
• A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants — Completed
• A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants — Completed
• A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or Obesity — Completed
• A Study to Assess the Tolerability and Safety of Subcutaneously (SC) Administered Immunoglobulin G (IgG) With Varying Injection Conditions — Completed